|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT138904014238N1 |
|
Date of registration:
|
2010-10-11 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of oral & intramuscular injection of methocarbamol and placebo on muscle strain
|
|
Scientific title:
|
Comparison effect of oral & intramuscular injection of methocarbamol and placebo on muscle strain |
|
Date of first enrolment:
|
2008-01-03 |
|
Target sample size:
|
105 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/4498 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Ruhallah Hossini
|
|
Address:
|
Yasuj Medical College
75917-94856
Yasuj
Iran (Islamic Republic of) |
|
Telephone:
|
+98 74 1222 8212 |
|
Email:
|
sa_jahanara@yahoo.com |
|
Affiliation:
|
Yasuj medical College |
|
|
Name:
|
Parviz Yazdanpanah
|
|
Address:
|
Yasuj, Beheshti hospital
75917-94856
Yasuj
Iran (Islamic Republic of) |
|
Telephone:
|
+98 74 1223 1005 |
|
Email:
|
pyazdanpanah@yums.ac.ir |
|
Affiliation:
|
Yasuj University of Medical Sciences |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion: Onset of pain (acute pain,<2week), No history of trauma Exclusion: Radiculopathy, Fracture, Infection, Ligament sprain, Malignancy, Diabetes Mellitus, Thyroid disease, Underlying disease, Rheumatic disease, Myopathy, Motor Neuron disease, Neuropathy
Exclusion criteria:
Age minimum:
20 years
Age maximum:
65 years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
M60-M79
|
Muscle strain.
M62.6
|
|
Intervention(s)
|
|
Oral Methocarbamol 2 tablet (1000 Milligram, q4h) for 3 days, then 2 tablet (q8h) for 4th days + Conventional treatment Naproxen (1 tablet, 500mg, q12h, for 7days)
|
|
Conventional treatment (Napoxen, 500 mg, q12h,for 7 days) + Placebo(1 tablet, q12h, for 7 days)
|
|
Methocarbamol, Intramuscular, 1 Ampule, 1000 milligram intramuscular in two buttocks + Conventional treatment Naproxen (1 tablet, 500mg, q12h, for 7days)
|
|
Intervention 1: Conventional treatment (Napoxen, 500 mg, q12h,for 7 days) + Placebo(1 tablet, q12h, for 7 days). Intervention 2: Methocarbamol, Intramuscular, 1 Ampule, 1000 milligram intramuscular in two buttocks + Conventional treatment Naproxen (1 tablet, 500mg, q12h, for 7days). Intervention 3: Oral Methocarbamol 2 tablet (1000 Milligram, q4h) for 3 days, then 2 tablet (q8h) for 4th days + Conventional treatment Naproxen (1 tablet, 500mg, q12h, for 7days).
|
|
Treatment - Drugs
|
|
Placebo
|
|
Primary Outcome(s)
|
|
Pain. Timepoint: In start of treatment and 7-10 days later. Method of measurement: Visual analogue scale.
|
|
Source(s) of Monetary Support
|
|
Yasuj University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Yasuj University of Medical Sciences
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|